News - Atrial fibrillation
For more information, please contact John David Hart at 800.961.4278 or johnhart@hartlaw.com or visit
Anti-Xa Therapy to Lower cardiovascular events in Addition to aspirin with/without thienopyridine therapy in Subjects with Acute Coronary S
New recommendations on devices, drugs and diagnosis in heart failure were launched at the Heart Failure Congress 2012, 19-22 May, in Belgrade, Serbia, and published in the European Heart Journal.
NEPTUNE, N.J., May 16, 2012 /PRNewswire-USNewswire/ -- iMPak Health, LLC announced today the launch of their new product, RhythmTrak, a Near Field Communication (NFC) enabled cardiovascular
A large cohort study has found that the strongest risk factors for atrial fibrillation in both men and women were a history of palpitations and hypertension.
